FDA Inspection 1196973 — Richard Drachtman, M.D.

Richard Drachtman, M.D. — FEI 3024857752

The FDA completed an inspection of Richard Drachtman, M.D. on Dec 22, 2022 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 22, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Brunswick, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.